sigle_v4
MDV-DEC_homepage_B_header-title

5th Transylvanian Meeting for Liver Interventions

The 5th Transylvanian Meeting for Liver Intervention is proposing this year to review two important issues in the management of advanced liver disease: portal hypertension and hepatocellular carcinoma.

The treatment of portal hypertension in special conditions could be challenging. Our proposal for discussion is:

  • HVPG guided therapy is more efficient than standard management?
  • What is the best approach to the gastric portal hypertensive lesions?
  • How non-variceal bleeding in patients with cirrhosis should be managed?

The management of hepatocellular carcinoma is multidisciplinary and challenging. From curative to palliative therapy sometime the borders are not that obvious and shifting from one to another may represent therapeutic options.  We propose and extensive review of the treatment options in hepatocellular carcinoma. Moreover, recently, concerns about relation between the new antiviral treatment for hepatitis C and the risk of hepatocellular carcinoma have been raised.

All the discussion will be driven by case presentations and pragmatic questions regarding different therapeutic dilemmas.

MEDIA
PARTNERS

04
02
05
03
01